Cytoreductive surgery for metastatic gastrointestinal stromal tumors treated with ripretinib: A single-center experience
Background: Cytoreductive surgery (CRS) has been advocated as an additional treatment with survival benefits for advanced gastrointestinal stromal tumor (GIST), especially in patients with responsive disease or focal progression after treatment with imatinib. Ripretinib is a fourth-line therapy for...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | Clinical Surgical Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773160X23000119 |